SCHEMBL12871548

SCHEMBL12871548

COc1ccc(C(Cc2ccccc2)(NC(=O)c2ccc(F)c(C(C)(F)F)c2)c2cc(F)cc(C(F)(F)F)c2)nc1

nearest known ligand 0.72

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CETP P11597 20/20 0.72
▸ KCNH2 Q12809 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1183820 0.95 CETP (0.79) CETPKCNH2
SCHEMBL12871529 0.90 CETP (0.89) CETPKCNH2
SCHEMBL12871530 0.90 CETP (0.89) CETPKCNH2
SCHEMBL12871524 0.88 CETP (0.74) CETPKCNH2
SCHEMBL1182918 0.85 CETP (0.87) CETPKCNH2
SCHEMBL1182920 0.85 CETP (0.87) CETPKCNH2
SCHEMBL1182381 0.84 CETP (0.82) CETPKCNH2
SCHEMBL1182382 0.84 CETP (0.82) CETPKCNH2
SCHEMBL1183096 0.84 CETP (1.00) CETPKCNH2
SCHEMBL1182520 0.84 CETP (1.00) CETPKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7888376-B2 Cholesteryl ester transfer protein (CETP) inhibitors; atherosclerosis and cardiovascular diseases; N-(1-(5-chloropyridin-2-yl)-1-(3-fluoro-5-(trifluoromethyl)phenyl)-2-phenylethyl)-4-(trifluoromethyl)thiazol-2-amine; Alzheimer's, atherosclerosis, venous thrombosis, peripheral vascular disease BRISTOL-MYERS SQUIBB COMPANY (US) 2011-02-15 — — US disclosed
Send feedback